B-cell prolymphocytic leukemia: Difference between revisions
Carlos Lopez (talk | contribs) No edit summary |
Carlos Lopez (talk | contribs) No edit summary |
||
Line 4: | Line 4: | ||
{{CMG}} {{CLG}} | {{CMG}} {{CLG}} | ||
{{SK}} B-PLL | {{SK}} B-PLL, Prolymphocytic leukemia, B-cell type | ||
==[[B-cell prolymphocytic leukemia overview|Overview]]== | ==[[B-cell prolymphocytic leukemia overview|Overview]]== |
Revision as of 15:24, 6 October 2015
B-cell prolymphocytic leukemia |
Differentiating B-cell prolymphocytic leukemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
B-cell prolymphocytic leukemia On the Web |
American Roentgen Ray Society Images of B-cell prolymphocytic leukemia |
Directions to Hospitals Treating B-cell prolymphocytic leukemia |
Risk calculators and risk factors for B-cell prolymphocytic leukemia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Carlos A Lopez, M.D. [2]
Synonyms and keywords: B-PLL, Prolymphocytic leukemia, B-cell type
Overview
Historical Perspective
Classification
Pathophysiology
Differentiating B-cell prolymphocytic leukemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | CT | MRI | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies